Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with severe aortic stenosis (a serious narrowing of a heart valve) that is causing symptoms, and your doctors have recommended a procedure called TAVI (a minimally invasive heart valve replacement)
- You are able to understand and follow the study instructions and rules
Who may not be able to join:
- You are already taking blood-thinning medication by mouth (such as for an irregular heartbeat called atrial fibrillation, blood clots, or because you have a mechanical heart valve)
- Your kidneys are not working well enough (below a certain level of kidney function), or you are already on dialysis or another form of kidney replacement treatment
- You are allergic to iodine-based contrast dye, or you have another condition that means you cannot have a CT scan of your heart
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ole De Backer, MD, PhD, FESC, The Heart Center, Rigshospitalet
Phone: +4535457086
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
At least one TAV leaflet with HALT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.